Female Sexual Dysfunction

Newly mapped enzyme could yield new treatments in sexual dysfunction

Published in Women's Health Weekly, July 24th, 2003

New research indicates that the enzyme arginase II, which can short-circuit a biochemical pathway leading to sexual arousal in men, is also present in the female genitalia and represents a promising target for new drugs to treat sexual dysfunction in women.

Scientists from the University of Pennsylvania (Penn), Temple University, and Boston University have mapped out arginase II's three-dimensional structure, easing the job of creating drugs to disable it. Their results will appear in the August 5, 2003, issue of the journal Biochemistry and were published June 26, 2003, on the journal's Web site.

"Existing treatments have shown little success...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Women's Health Weekly

Source: Women's Health Weekly (2003-07-24)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry